About ReadCoor
ReadCoor is a Healthcare company based in Cambridge (United States) founded in 2016, and was acquired by 10X Genomics in October 2020. Fluorescent in situ RNA sequencing technology. It operates in the Healthcare and Technology sectors. ReadCoor has raised $55.61 million across 5 funding rounds from investors including 10X Genomics, The Chan Zuckerberg Initiative and Gates Foundation. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its legal entity is READCOOR, INC. Its competitors include PacBio, Alnylam and Omniome; 3 of its 3 listed competitors have raised funding.
Company details
ReadCoor was founded in 2016 in Cambridge, United States, within the biotechnology sector. A next-generation sequencing platform is being developed and commercialized, allowing high-throughput RNA sequencing alongside preservation of sample morphology and integration of spatial imaging data. FISSEQ technology supports applications in drug development, pathogen identification, disease diagnostics, regenerative medicine, immuno-oncology, gene therapy, and brain diseases, originating from Harvards Dr. Church lab.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Website readcoor.com
- Social LinkedIn YouTube
- Acquired by 10X Genomics (Oct 2020)
- Legal Name Readcoor, Inc.
- Total Equity Funding$55.61M (USD)
in 5 rounds
- Latest Funding Round$30M (USD), Series B
Jan 2020
- Investors10X Genomics
& 8 more
- Acquired by10X Genomics
(Oct 2020)
Apps and channels of ReadCoor
its YouTube channel 10x Genomics has 6.98K subscribers and 30 videos.
Videos from ReadCoor
The most watched videos on ReadCoor's YouTube channel, 10x Genomics (6.98K subscribers). Click a video to play it here.
More on 10x Genomics.
Funding Insights of ReadCoor
ReadCoor has successfully raised a total of $55.61M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $55.61M
- Total Rounds 5
- Last Round Series B — $30M
- First Round $23M
(Sep 2016)
- Investors Count 8
All 5 funding rounds of ReadCoor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $30M | Series B | – | Pavilion Capital Partners | |
| Jul 2019 | $2.61M | Series A | – | – | – |
| Jan 2018 | Grant | – | – | ||
| Dec 2016 | Grant | – | – | ||
| Sep 2016 | $23M | Series A | – | Decheng Capital |
9 investors in total: 8 institutional and 1 angel.
Investors in ReadCoor
ReadCoor has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include 10X Genomics, The Chan Zuckerberg Initiative and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage companies are invested in by this venture capital fund. | pavilioncapital.com | New York, United States | ||
Venture capital firm focused on life science and technology sectors | decheng.com | Shanghai, China | ||
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
Foundation engaged in the areas of science, education, and justice | 2015 | chanzuckerberg.com | Redwood City, United States | |
Truck brands are manufactured by DAF in Eindhoven, Netherlands. | 1928 | daf.com | Eindhoven, Netherlands | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
| lillyasiaventures.com | ||||
HW Hansjorg Wyss | unknown_01930b6f0a6d4e269 | |||
Instrument systems for genomic research and sequencing libraries are developed. | 2012 | 10xgenomics.com | Pleasanton, United States |
Investor details for ReadCoor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ReadCoor
4 dated milestones of ReadCoor across 4 years, from founding to its latest funding, stage changes and deals.
- Founded ReadCoor is founded.
- Funding First funding round of $23.0M.
- Funding Latest funding round, Series B, of $30.0M.
- Exit Acquired by 10X Genomics.
Competitors of ReadCoor
ReadCoor has 3 listed competitors in our database, 3 of them funded. They include PacBio, Alnylam and Omniome.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. |
Detailed competitors of ReadCoor
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ReadCoor (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Readcoor
Complete news archive for ReadCoor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ReadCoor
ReadCoor was founded in 2016.
ReadCoor is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
ReadCoor is a funded company, having raised a total of $55.61M across 5 funding rounds to date. The company's 1st funding round was a Series A of $23M, raised on Sep 2016.
ReadCoor was founded in 2016 in Cambridge, United States, within the biotechnology sector. A next-generation sequencing platform is being developed and commercialized, allowing high-throughput RNA sequencing alongside preservation of sample morphology and integration of spatial imaging data. FISSEQ technology supports applications in drug development, pathogen identification, disease diagnostics, regenerative medicine, immuno-oncology, gene therapy, and brain diseases, originating from Harvards Dr. Church lab.
ReadCoor has 9 investors. Key investors include 10X Genomics, The Chan Zuckerberg Initiative, Gates Foundation, DAF Trucks, and Pavilion Capital Partners.
ReadCoor operates through Readcoor, Inc..
Yes. ReadCoor was acquired by 10X Genomics in October 2020.

